Living Cell Technologies is a fast-growing biotechnology company with a dual listing on the Australian Securities Exchange (ASX:LCT) and the international OTCQX (LVCLY).

LCT has more than 1800 shareholders from Australasia, Europe and the US and is working to further strengthen its international shareholder base.

LCT is committed to clear and transparent communication with its investors and adheres strictly to corporate governance guidelines.